青光眼的干细胞治疗：可能性与实际应用
Stem cell therapy for glaucoma: possibilities and practicalities.
作者信息
Johnson Thomas V, Bull Natalie D, Martin Keith R
机构信息
Cambridge Centre for Brain Repair, University of Cambridge ED Adrian Building Forvie Site, Robinson Way, Cambridge, CB2 OPY, UK.
出版信息
Expert Rev Ophthalmol. 2011 Apr 1;6(2):165-174. doi: 10.1586/eop.11.3.
Abstract
Glaucoma is a progressive, neurodegenerative, optic neuropathy in which currently available therapies cannot always prevent, and do not reverse, vision loss. Stem cell transplantation may provide a promising new avenue for treating many presently incurable degenerative conditions, including glaucoma. This article will explore the various ways in which transplantation of stem or progenitor cells may be applied for the treatment of glaucoma. We will critically discuss the translational prospects of two cell transplantation-based treatment modalities: neuroprotection and retinal ganglion cell replacement. In addition, we will identify specific questions that need to be addressed and obstacles to overcome on the path to clinical translation, and offer insight into potential strategies for approaching this goal.
摘要
青光眼是一种进行性神经退行性视神经病变，目前可用的治疗方法并不能总是预防视力丧失，也无法使其逆转。干细胞移植可能为治疗包括青光眼在内的许多目前无法治愈的退行性疾病提供一条有前景的新途径。本文将探讨干细胞或祖细胞移植可用于治疗青光眼的各种方式。我们将批判性地讨论基于细胞移植的两种治疗模式的转化前景：神经保护和视网膜神经节细胞替代。此外，我们将确定在临床转化道路上需要解决的具体问题和需要克服的障碍，并深入探讨实现这一目标的潜在策略。
相似文献
1
Stem cell therapy for glaucoma: possibilities and practicalities.青光眼的干细胞治疗：可能性与实际应用
Expert Rev Ophthalmol. 2011 Apr 1;6(2):165-174. doi: 10.1586/eop.11.3.
2
Damage and repair in retinal degenerative diseases: Molecular basis through clinical translation.视网膜退行性疾病中的损伤与修复：从分子基础到临床转化
Neural Regen Res. 2026 Apr 1;21(4):1383-1395. doi: 10.4103/NRR.NRR-D-24-01016. Epub 2025 Feb 24.
3
Pluripotent Stem Cell-Based Approaches to Explore and Treat Optic Neuropathies.基于多能干细胞的视神经病变探索与治疗方法。
Front Neurosci. 2018 Sep 20;12:651. doi: 10.3389/fnins.2018.00651. eCollection 2018.
4
[Aiming for zero blindness].追求零失明
Nippon Ganka Gakkai Zasshi. 2015 Mar;119(3):168-93; discussion 194.
5
Cell replacement with stem cell-derived retinal ganglion cells from different protocols.采用不同方案由干细胞衍生的视网膜神经节细胞进行细胞替代。
Neural Regen Res. 2024 Apr;19(4):807-810. doi: 10.4103/1673-5374.381494.
6
Retinal Tissue Bioengineering, Materials and Methods for the Treatment of Glaucoma.视网膜组织工程学，青光眼治疗的材料和方法。
Tissue Eng Regen Med. 2020 Jun;17(3):253-269. doi: 10.1007/s13770-020-00254-8. Epub 2020 May 10.
7
Retinal ganglion cell repopulation for vision restoration in optic neuropathy: a roadmap from the RReSTORe Consortium.视网膜神经节细胞再灌注以恢复视神经病变的视力：RReSTORe 联盟的路线图。
Mol Neurodegener. 2023 Sep 21;18(1):64. doi: 10.1186/s13024-023-00655-y.
8
The potential of stem cell research for the treatment of neuronal damage in glaucoma.干细胞研究治疗青光眼神经元损伤的潜力。
Cell Tissue Res. 2013 Aug;353(2):311-25. doi: 10.1007/s00441-013-1646-2. Epub 2013 May 25.
9
[The advances in research on precisely inducing retinal ganglion cells from stem cells].[干细胞精准诱导视网膜神经节细胞的研究进展]
Zhonghua Yan Ke Za Zhi. 2017 May 11;53(5):381-385. doi: 10.3760/cma.j.issn.0412-4081.2017.05.013.
10
Stem Cell-Based Therapies for Glaucoma Treatment: A Review Bridging the Gap in Veterinary Patients.基于干细胞的青光眼治疗方法：一篇弥合兽医患者差距的综述
Int J Mol Sci. 2024 Dec 30;26(1):232. doi: 10.3390/ijms26010232.
引用本文的文献
1
Stem Cell-Based Therapies for Glaucoma Treatment: A Review Bridging the Gap in Veterinary Patients.基于干细胞的青光眼治疗方法：一篇弥合兽医患者差距的综述
Int J Mol Sci. 2024 Dec 30;26(1):232. doi: 10.3390/ijms26010232.
2
The Future of Stem Cells and Their Derivates in the Treatment of Glaucoma. A Critical Point of View.干细胞及其衍生细胞在青光眼治疗中的未来。一个关键的观点。
Int J Mol Sci. 2021 Oct 14;22(20):11077. doi: 10.3390/ijms222011077.
3
Cell-Based Therapies for Trabecular Meshwork Regeneration to Treat Glaucoma.基于细胞的小梁网再生疗法治疗青光眼。
Biomolecules. 2021 Aug 24;11(9):1258. doi: 10.3390/biom11091258.
4
Commentary: Understanding irreversible blindness - The need of the hour; Reversing it - The need of the future!评论：理解不可逆失明——当下之需；逆转它——未来之需！
Indian J Ophthalmol. 2021 Oct;69(10):2636-2637. doi: 10.4103/ijo.IJO_1224_21.
5
The internal limiting membrane: Roles in retinal development and implications for emerging ocular therapies.内界膜：在视网膜发育中的作用及其对新兴眼部治疗方法的影响。
Exp Eye Res. 2021 May;206:108545. doi: 10.1016/j.exer.2021.108545. Epub 2021 Mar 20.
6
Intravitreal stem cell paracrine properties as a potential neuroprotective therapy for retinal photoreceptor neurodegenerative diseases.玻璃体内干细胞旁分泌特性作为视网膜光感受器神经退行性疾病的一种潜在神经保护疗法。
Neural Regen Res. 2020 Sep;15(9):1631-1638. doi: 10.4103/1673-5374.276324.
7
A Promising Tool in Retina Regeneration: Current Perspectives and Challenges When Using Mesenchymal Progenitor Stem Cells in Veterinary and Human Ophthalmological Applications.在视网膜再生方面有希望的工具：在兽医和人眼科学应用中使用间充质祖细胞时的当前观点和挑战。
Stem Cell Rev Rep. 2017 Oct;13(5):598-602. doi: 10.1007/s12015-017-9750-4.
8
Predegenerated Schwann cells--a novel prospect for cell therapy for glaucoma: neuroprotection, neuroregeneration and neuroplasticity.退变的雪旺细胞——青光眼细胞治疗的新前景：神经保护、神经再生和神经可塑性。
Sci Rep. 2016 Apr 1;6:23187. doi: 10.1038/srep23187.
9
Time-Lapse Retinal Ganglion Cell Dendritic Field Degeneration Imaged in Organotypic Retinal Explant Culture.器官型视网膜外植体培养中成像的延时视网膜神经节细胞树突野退化
Invest Ophthalmol Vis Sci. 2016 Jan 1;57(1):253-64. doi: 10.1167/iovs.15-17769.
10
Current perspective of neuroprotection and glaucoma.神经保护与青光眼的当前观点
Clin Ophthalmol. 2015 Nov 11;9:2109-18. doi: 10.2147/OPTH.S80445. eCollection 2015.
本文引用的文献
1
Intravitreal injections of neurotrophic factors secreting mesenchymal stem cells are neuroprotective in rat eyes following optic nerve transection.间质干细胞分泌神经营养因子的玻璃体内注射对视神经切断后的大鼠眼具有神经保护作用。
Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6394-400. doi: 10.1167/iovs.09-4310. Epub 2010 Oct 6.
2
Neurotrophic factor delivery as a protective treatment for glaucoma.神经营养因子递呈作为青光眼的保护性治疗。
Exp Eye Res. 2011 Aug;93(2):196-203. doi: 10.1016/j.exer.2010.05.016. Epub 2010 Jun 1.
3
Current approaches and future prospects for stem cell rescue and regeneration of the retina and optic nerve.当前用于干细胞挽救和视网膜及视神经再生的方法及未来展望。
Can J Ophthalmol. 2010 Aug;45(4):333-41. doi: 10.3129/i10-077.
4
Cortical plasticity induced by inhibitory neuron transplantation.抑制性神经元移植诱导的皮层可塑性。
Science. 2010 Feb 26;327(5969):1145-8. doi: 10.1126/science.1183962.
5
6
Communication via gap junctions underlies early functional and beneficial interactions between grafted neural stem cells and the host.缝隙连接通讯为移植的神经干细胞与宿主之间的早期功能和有益相互作用提供了基础。
Proc Natl Acad Sci U S A. 2010 Mar 16;107(11):5184-9. doi: 10.1073/pnas.0915134107. Epub 2010 Feb 10.
7
Generation, purification and transplantation of photoreceptors derived from human induced pluripotent stem cells.人诱导多能干细胞来源的光感受器的产生、纯化和移植。
PLoS One. 2010 Jan 20;5(1):e8763. doi: 10.1371/journal.pone.0008763.
8
Mesenchymal stem cell-secreted superoxide dismutase promotes cerebellar neuronal survival.间充质干细胞分泌的超氧化物歧化酶促进小脑神经元存活。
J Neurochem. 2010 Sep;114(6):1569-80. doi: 10.1111/j.1471-4159.2009.06553.x. Epub 2010 Aug 19.
9
Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat.人诱导多能干细胞来源的视网膜色素上皮细胞移植对视网膜变性大鼠的保护作用。
PLoS One. 2009 Dec 3;4(12):e8152. doi: 10.1371/journal.pone.0008152.
10
Triamcinolone attenuates macrophage/microglia accumulation associated with NMDA-induced RGC death and facilitates survival of Müller stem cell grafts.曲安奈德可减轻 NMDA 诱导的 RGC 死亡相关的巨噬细胞/小胶质细胞聚集，并促进 Muller 干细胞移植物的存活。
Exp Eye Res. 2010 Feb;90(2):308-15. doi: 10.1016/j.exer.2009.11.008. Epub 2009 Dec 4.
Zotero 插件